3000+ people. More than 20 global locations. One expert team. Everything we do—from the services we offer to the products we provide—is made possible by our people. Our team of experts, innovators and leaders has helped hundreds of clients navigate complex R&D and manufacturing challenges. Now, we await yours.
Steve Lavezoli
Vice President of Biologics
Steve Lavezoli is Curia’s Vice President of Biologics overseeing its discovery, development and manufacturing services.
With a remarkable breadth of experience, Steve most recently worked for Scorpius Biologics, a startup CDMO focused on microbial and mammalian biologics development and manufacturing as the vice president of commercial operations. Prior to joining Scorpius, he spent four years with Catalent Biologics, focused on drug substance business development in the U.S. for early-stage clinical programs and later focusing on late-stage commercial program integration. He also spent 12 years in the industrial gasses industry with Linde Gas before joining W.L. Gore in the startup biopharmaceutical division to work on a commercial business/market development role for bulk drug substance single-use items.
Steve earned his B.S. in chemical engineering from Pennsylvania State University.